ArticleCancer research communications2026

CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy.

Shiney Chandraganti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.